Mizuho Financial Group Inc. Sponosred ADR (Japan) vs Revolution Medicines Inc. Common Stock — how do they compare? Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.41 (market cap $127.85B), while Revolution Medicines Inc. Common Stock trades at $188.5 (market cap $40.32B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 3.2× Revolution Medicines Inc. Common Stock's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.72% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mizuho Financial Group Inc. Sponosred ADR (Japan) for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| MFG | RVMD | |
|---|---|---|
Market Cap | $127.85B | $40.32B |
Volume | 3,950,750 | 4,855,734 |
Sector | Financials | Health |
52-Week High | $11.45 | $221.15 |
52-Week Low | $6.09 | $47.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $35.14T | $37.02B |
Dividend Yield | 1.72% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →